Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FG1FS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,144
Award facts
- Contract value 100% obligated
- $12,144.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,144.01 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packages) on November 18, 2025, with an ultimate completion date of November 19, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania.
This delivery order supports the Defense Logistics Agency's Medical Supply Chain mission to furnish pharmaceutical products to military and veteran healthcare systems. RINVOQ (upadacitinib) is a targeted immunosuppressant used in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the comprehensive therapeutic range of medications supplied through AmerisourceBergen's prime vendor relationship with the DLA. The company's substantial IDC serves as a global pharmaceutical support vehicle enabling flexible procurement of brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FG1FS?
SPE2DR26FG1FS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FG1FS worth?
The government has obligated $12,144 on SPE2DR26FG1FS.
Is contract SPE2DR26FG1FS an order under another contract?
Yes. SPE2DR26FG1FS is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1FS competed?
The extent of competition for SPE2DR26FG1FS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award